INVO Bioscience CEO Steven Shum receives $1.3M in 2019
INVO Bioscience reports 2019 executive compensation
By ExecPay News
Published: November 20, 2020
INVO Bioscience reported fiscal year 2019 executive compensation information on November 20, 2020.
In 2019, six executives at INVO Bioscience received on average a compensation package of $459K, a 99% increase compared to previous year.
Average pay of disclosed executives at INVO Bioscience
Steven Shum, Chief Executive Officer, received $1.3M in total. 93% of Shum's compensation, or $1.3M, was in option awards. Shum also received $73K in salary and $18K in stock awards.
Kathleen Karloff, Chief Executive Officer, received a compensation package of $527K, which increased by 339% compared to previous year. 67% of the compensation package, or $352K, was in option awards.
Robert Bowdring, Chief Financial Officer, earned $366K in 2019, a 205% increase compared to previous year.
Michael Campbell, Chief Operating Officer, received $259K in 2019.
Lori Marzilli-Kahler, Former VP, Global Operations, earned $185K in 2019, a 66% decrease compared to previous year.
Debra Hoopes, Chief Financial Officer, received $70K in 2019.
Related executives
Kathleen Karloff
INVO Bioscience
Chief Executive Officer
Steven Shum
INVO Bioscience
Chief Executive Officer
Michael Campbell
INVO Bioscience
Chief Operating Officer
Lori Marzilli-Kahler
INVO Bioscience
Former VP, Global Operations
Robert Bowdring
INVO Bioscience
Chief Financial Officer
Debra Hoopes
INVO Bioscience
Chief Financial Officer
You may also like
Source: SEC filing on November 20, 2020.